Tumor volume of resectable adenocarcinoma of the esophagogastric junction at multidetector CT: Association with regional lymph node metastasis and N stage

Radiology

Volumn 269, Issue 1, 2013, Pages 130-138

  Li, Rui ^a   Chen, Tian Wu ^a   Hu, Jiani ^b   Guo, Dan Dan ^a   Zhang, Xiao Ming ^a   Deng, Dan ^a   Li, Hang ^a   Chen, Xiao Li ^a   Tang, Hong Jie ^a  

^a AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IOPAMIDOL; IOPROMIDE;

ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; COMPUTED TOMOGRAPHY SCANNER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TREATMENT DURATION; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHINA; COMORBIDITY; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84884680280     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13122269     Document Type: Article

References (36)

1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83(10):2049-2053. (Pubitemid 28525384)
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97(2):142-146. (Pubitemid 40277094)
3. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29(4):645-654. (Pubitemid 30612230)
4. de Manzoni G, Pedrazzani C, Verlato G, et al. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction. Br J Surg 2004;91(3):296-303. (Pubitemid 38375768)
5. Collard JM. Exclusive radical surgery for esophageal adenocarcinoma. Cancer 2001;91(6):1098-1104.
6. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277-300.
7. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg 2010;251(1):46-50.
8. Saha S, Dehn TC. Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction. Dis Esophagus 2001;14(1):32-36. (Pubitemid 32700508)
9. Okuda I, Kokubo T, Hoshihara Y, Udagawa H. Imaging diagnosis of esophageal carcinoma by computed tomography and magnetic resonance imaging [in Japanese]. Nippon Geka Gakkai Zasshi 2002;103(4):331-336.
10. Schröder W, Baldus SE, Mönig SP, Beckurts TK, Dienes HP, Hölscher AH. Lymph node staging of esophageal squamous cell carcinoma in patients with and without neoadjuvant radiochemotherapy: histomorphologic analysis. World J Surg 2002;26(5):584-587. (Pubitemid 36920370)
11. Ott K, Weber W, Siewert JR. The importance of PET in the diagnosis and response evaluation of esophageal cancer. Dis Esophagus 2006;19(6):433-442. (Pubitemid 44644678)
12. Fang WL, Wu CW, Chen JH, et al. Esophagogastric junction adenocarcinoma according to Siewert classification in Taiwan. Ann Surg Oncol 2009;16(12):3237-3244.
13. Barbour AP, Jones M, Brown I, et al. Risk stratification for early esophageal adenocarcinoma: analysis of lymphatic spread and prognostic factors. Ann Surg Oncol 2010;17(9):2494-2502.
14. Roedl JB, Prabhakar HB, Mueller PR, Colen RR, Blake MA. Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: the incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements. Acad Radiol 2009;16(2):218-226.
15. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 1998;85(11):1457-1459. (Pubitemid 28502569)
16. Ielpo B, Pernaute AS, Elia S, et al. Impact of number and site of lymph node invasion on survival of adenocarcinoma of esophagogastric junction. Interact Cardiovasc Thorac Surg 2010;10(5):704-708.
17. Pedrazzani C, de Manzoni G, Marrelli D, et al. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma. J Thorac Cardiovasc Surg 2007;134(2):378-385. (Pubitemid 47088597)
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC cancer staging manual. 7th ed. New York, NY: Springer, 2010; 103-115.
19. Kikuchi S, Hiki Y, Sakakibara Y, Kakita A, Kuwao S. Measuring the tumor volume of gastric carcinoma by computer image analysis: clinical significance. World J Surg 2000;24(5):603-607. (Pubitemid 30210853)
20. Gossios K, Tsianos E, Prassopoulos P, Papakonstantinou O, Tsimoyiannis E, Gourtsoyiannis N. Usefulness of the non-distension of the stomach in the evaluation of perigastric invasion in advanced gastric cancer by CT. Eur J Radiol 1998;29(1):61-70. (Pubitemid 29052395)
21. Moss AA, Schnyder P, Thoeni RF, Margulis AR. Esophageal carcinoma: pretherapy staging by computed tomography. AJR Am J Roentgenol 1981;136(6):1051-1056. (Pubitemid 12236543)
22. Johnson CR, Khandelwal SR, Schmidt-Ullrich RK, Ravalese J III, Wazer DE. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int J Radiat Oncol Biol Phys 1995;32(3):635-641.
23. Gertler R, Stein HJ, Loos M, Langer R, Friess H, Feith M. How to classify adenocarcinomas of the esophagogastric junction: as esophageal or gastric cancer? Am J Surg Pathol 2011;35(10):1512-1522.
24. Meier I, Merkel S, Papadopoulos T, Sauer R, Hohenberger W, Brunner TB. Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition. Int J Radiat Oncol Biol Phys 2008;70(5):1408-1417. (Pubitemid 351417761)
25. Sasako M, Sano T, Yamamoto S, et al. Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 2006;7(8):644-651. (Pubitemid 44123569)
26. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366(22):2074-2084.
27. Rice TW, Zuccaro G Jr, Adelstein DJ, Rybicki LA, Blackstone EH, Goldblum JR. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg 1998;65(3):787-792. (Pubitemid 28162480)
28. Kimura Y, Sumi M, Ichikawa Y, Kawai Y, Nakamura T. Volumetric MR imaging of oral, maxillary sinus, oropharyngeal, and hypopharyngeal cancers: correlation between tumor volume and lymph node metastasis. AJNR Am J Neuroradiol 2005;26(9):2384-2389.
29. Kuriakose MA, Loree TR, Hicks WL, Welch JJ, Wang H, DeLacure MD. Tumour volume estimated by computed tomography as a predictive factor in carcinoma of the tongue. Br J Oral Maxillofac Surg 2000;38(5):460-465.
30. Li H, Chen TW, Li ZL, et al. Tumour size of resectable oesophageal squamous cell carcinoma measured with multidetector computed tomography for predicting regional lymph node metastasis and N stage. Eur Radiol 2012;22(11):2487-2493.
31. Tachimori Y, Kato H, Watanabe H, Sasako M, Kinoshita T, Maruyama K. Difference between carcinoma of the lower esophagus and the cardia. World J Surg 1996;20(4):507-510; discussion 511.
32. Kodama I, Kofuji K, Yano S, et al. Lymph node metastasis and lymphadenectomy for carcinoma in the gastric cardia: clinical experience. Int Surg 1998;83(3):205-209. (Pubitemid 128463239)
33. Kakeji Y, Yamamoto M, Ito S, et al. Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection. Surg Today 2012;42(4):351-358.
34. Ueda Y, Shiozaki A, Itoi H, et al. The range of tumor extension should have precedence over the location of the deepest tumor center in determining the regional lymph node grouping for widely extending esophageal carcinomas. Jpn J Clin Oncol 2006;36(12):775-782. (Pubitemid 47090732)
35. Hermans R, Feron M, Bellon E, Dupont P, Van den Bogaert W, Baert AL. Laryngeal tumor volume measurements determined with CT: a study on intra- and interobserver variability. Int J Radiat Oncol Biol Phys 1998;40(3):553-557. (Pubitemid 28104224)
36. Beer AJ, Wieder HA, Lordick F, et al. Adenocarcinomas of esophagogastric junction: multi-detector row CT to evaluate early response to neoadjuvant chemotherapy. Radiology 2006;239(2):472-480.